In line with this, higher levels of SP-D were observed in BAL of patients under steroid treatment [16], while treatment with oral steroids leads to a decline in serum to SP-D concentrations of COPD patients [12]. The gene discussed is SFTPD; the disease is chronic obstructive pulmonary disease.